Fluarix Tetra

Fluarix Tetra is an influenza vaccine designed to protect against four strains of the flu virus. This vaccine is administered intramuscularly and is manufactured by Glaxosmithkline Biologicals S.A. in the EU.

Fluarix Tetra is used to prevent influenza caused by the B/Phuket/3073/2013-like virus and the Influenza Virus B/Austria/1359417/2020. This vaccine is typically administered annually to help reduce the risk of flu infection. It is often recommended for individuals who are at higher risk of complications from the flu, such as the elderly, young children, and those with chronic health conditions.

Common effects of Fluarix Tetra may include soreness, redness, or swelling at the injection site. Some individuals may also experience mild flu-like symptoms such as fever, fatigue, or muscle aches. These effects are usually temporary and resolve on their own within a few days.

Fluarix Tetra should be administered with caution in individuals with a history of severe allergic reactions to previous influenza vaccines or any of its components. It is important to inform your healthcare provider about any allergies or medical conditions before receiving the vaccine. Always follow the advice of a healthcare professional regarding the administration of this vaccine.

Fluarix Tetra may interact with certain medications or other vaccines. It is advisable to discuss any current medications or recent vaccinations with a healthcare provider before receiving Fluarix Tetra. Additionally, individuals with weakened immune systems should consult their healthcare provider to determine the appropriate timing and safety of receiving this vaccine.